98%
921
2 minutes
20
Introduction: Percutaneous cholecystostomy (PC) is an effective procedure to treat moderate or severe acute cholecystitis (AC) in high-risk patients. The ideal timing of the drainage removal is argued. The aim of this study is to analyze our experience and perform a systematic review about the ideal timing of a percutaneous cholecystostomy (PC) tube removal.
Evidence Acquisition: A web-based literature search was performed and studies reporting the length of the catheter maintenance were analyzed. A regression analysis between the timing of tube removal and morbidity, mortality and disease recurrence was performed. Patients who underwent PC as definitive treatment of moderate or severe acute cholecystitis at our institution between 2011 to 2015 were analyzed. Clinical and technical success, morbidity, mortality and recurrence rates were retrospectively retrieved from a perspective database.
Evidence Synthesis: The systematic review yield to analyze 50 studies. None of them focused exclusively on outcome measures in relation to PC tube duration. The timing of the drain removal varied from 2 to 193 days. Regression analyses showed no correlation between length of tube maintenance and the considered outcomes. We studied 35 patients. The median age was 78 (range 52-94) and 88.5% had an ASA score ≥3. P-POSSUM estimated morbidity was 68.7% (range 34.3-99.0) and mortality was 15.8% (range 1.9-80.2). Clinical success was 97.1%. Procedure-related morbidity was 34.3%: 2 abscess, 1 bleeding, 1 biloma and 8 tube dislodgment. Biliary leakage was not observed. The observed 30-day overall mortality was 11.4%. The median follow-up was 16 months. Recurrence rate was 12.1%.
Conclusions: PC is an effective procedure in high-risk patients with moderate or severe AC. At the moment there is no evidence whether the duration of PC tube may affect outcome.
Download full-text PDF |
Source |
---|
JAMA Surg
September 2025
Department of Surgery, Veterans Affairs Boston Health Care System, Boston, Massachusetts.
Importance: Use of percutaneous cholecystostomy (PC) has increased over the past 20 years without consensus regarding indications and management.
Objective: To identify indicators for PC, clarify the management of a PC tube (PCT), and suggest the timing of further interventions.
Evidence Review: A systematic review was conducted to identify studies examining PC.
Background/aims: This study aimed to review and update the evidence regarding the efficacy and safety of percutaneous cholecystolithotomy/lithotripsy (PCCL) for managing acute calculous cholecystitis (ACC) in non-surgical candidates.
Methods: A systematic search of PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), and Embase was conducted. We included studies focusing on the use of PCCL in patients deemed ineligible for surgery owing to ACC and reporting outcomes such as technical success, stone clearance, recurrence, and length of hospital stay.
Cureus
July 2025
Department of General Surgery, Southend University Hospital, Southend, GBR.
Introduction Laparoscopic cholecystectomy for acute cholecystitis (hot cholecystectomy) is known to be associated with increased operative difficulty and a higher risk of intraoperative biliovascular complications. Certain bailout strategies have been formulated to mitigate these risks. Most guidelines recommend surgery within seven days of onset of inflammation.
View Article and Find Full Text PDFSurgery
July 2025
Department of General Surgery, Quality Improvement & Patient Safety, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH; Department of General Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH. Electronic address:
Background: Laparoscopic cholecystectomy is the gold standard for treating acute calculous cholecystitis, whereas percutaneous cholecystostomy is typically reserved for patients at prohibitive surgical risk, given its greater complication rates. This multisite quality improvement initiative aimed to reduce the use of percutaneous cholecystostomy in patients at acceptable risk for surgery.
Methods: In October 2023, a multidisciplinary team implemented an acute calculous cholecystitis care pathway across 8 teaching hospitals.
Abdom Radiol (NY)
July 2025
Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
Acute cholecystitis (AC) and acute cholangitis (ACh) are common biliary conditions that can range in clinical severity from mild discomfort to life-threatening complications. The Tokyo Guidelines (TG) recommend a diagnostic approach that integrates clinical signs, laboratory findings, and imaging features to improve diagnostic accuracy. However, diagnosis might be difficult given overlapping clinical symptoms and the different imaging presentations of different disorders.
View Article and Find Full Text PDF